119th Congress
H.R. 1796
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025
- Introduced
- In committee
- Passed House
- Passed Senate
- To President
- Became law
- Sponsor
- John James(R-MI)
- Introduced
- Mar 3, 2025
- Policy area
- Health
- Committees
- House Committee on Energy and Commerce
- Official text
- Introduced in House · Congress.gov page
Cosponsors (6)
Original cosponsors (4)
- Danny K. Davis (D-IL)
- Jennifer A. Kiggans (R-VA)
- Marc A. Veasey (D-TX)
- Troy A. Carter (D-LA)
Added later (2)
- Eugene Simon Vindman (D-VA) · Aug 15, 2025
- Sanford D. Bishop, Jr. (D-GA) · Jan 16, 2026
Summary
No Congressional Research Service summary yet. CRS usually publishes one a few weeks after a bill is introduced.
Official title: To amend the Public Health Service Act to reauthorize a sickle cell disease prevention and treatment demonstration program.
Latest action(Mar 3, 2025): Referred to the House Committee on Energy and Commerce.
Roll-call votes
No recorded votes on this bill.
Actions
- Mar 3, 2025 · House
Referred to the House Committee on Energy and Commerce. - Mar 3, 2025
Introduced in House